Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
about
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyA critical appraisal of atomoxetine in the management of ADHDAssociations of sleep disturbance with ADHD: implications for treatmentPsychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorderCardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate.A systematic review of the safety of lisdexamfetamine dimesylate.Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trialTreatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management.Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidateAnimal model of methylphenidate's long-term memory-enhancing effects.Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update.Pozanicline for the treatment of attention-deficit/hyperactivity disorder.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison.Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD.Atomoxetine treatment for children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology.Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder.Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.Evaluation of a head-to-head study of lisdexamfetamine dimesylate and atomoxetine: evaluation of Dittmann RW, Cardo E, Nagy P, et al. Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivAttention-Deficit/Hyperactivity Disorder.
P2860
Q26750486-39B8445E-1FCD-493A-BCFA-077A4FECFC46Q26771187-CD749780-511C-4E15-A363-F570F2DA218CQ27027062-91EE0989-508B-458F-9E3F-C468F89D0A25Q27303963-1DF7CD5D-A727-494D-A8F0-FE99E4013240Q30399107-CDAD36CF-B550-4D32-8B59-62AA9093A4BEQ30489718-84E307FB-C94B-40DE-92E4-AFB00E242DFCQ33755396-8053EEE1-23D1-4076-B3BA-09841AEAF6FBQ34449469-05C2EAA0-1CE6-4587-BC8A-69BD96A9A80DQ34459431-E89979DB-9847-4DF7-88AF-3987CEC974BFQ34677664-619CA10F-3FC6-494D-BDAC-A3298B3C8F84Q36526984-0BEE3AAD-1892-4141-AB34-B2E6048FFCAAQ37491483-935E1E88-9F49-497F-99AC-1CE8F4504D41Q38176839-178094EA-A789-462E-852E-AFEEDF9DF243Q38221823-D64B8B72-EDFE-4E55-BF93-607033D522FEQ38240014-F03A85DE-9B5F-4E9E-9C7C-50E7364B38AFQ38246678-88BE853D-50E8-473E-8B06-685A7721D689Q38362252-072A6F61-E1A2-4620-99DD-6ED3C99C7D29Q38374695-97DEE28E-4E9B-44B2-8BA5-808B657F5D8DQ38862420-480D31DF-0DA4-4149-B508-D3D44C2A9E54Q38930427-BD3B14F6-D102-4F88-8D3D-151F48C854F0Q39036187-DE7747AB-0B29-414B-91CE-CB542D3D2F3AQ39097761-52B129B8-4190-403B-8AF8-C565C4A929F9Q46584563-2EE0EA5B-34F4-4E00-8F0C-224A9E5F8CF2Q47550500-C594B405-1CA3-4281-BF34-B875AB8AF8F5Q50629913-74325296-44F6-44C5-8D13-69C0780A8352Q51805679-E8059CD1-428E-4E08-AC79-C94D63AE61C7
P2860
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of lisdexa ...... ouble-blind, phase IIIb study.
@en
Efficacy and safety of lisdexa ...... ouble-blind, phase IIIb study.
@nl
type
label
Efficacy and safety of lisdexa ...... ouble-blind, phase IIIb study.
@en
Efficacy and safety of lisdexa ...... ouble-blind, phase IIIb study.
@nl
prefLabel
Efficacy and safety of lisdexa ...... ouble-blind, phase IIIb study.
@en
Efficacy and safety of lisdexa ...... ouble-blind, phase IIIb study.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of lisdexa ...... double-blind, phase IIIb study
@en
P2093
Andrew Lyne
Beatriz Caballero
Colleen S Anderson
Esther Cardo
Nicholas Higgins
Paul Hodgkins
Ralf W Dittmann
Ralph Bloomfield
Richard Civil
P2860
P2888
P304
P356
10.1007/S40263-013-0104-8
P577
2013-12-01T00:00:00Z